Study Watch vs iPredict Eye Screening
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Study Watch focuses on continuous physiological monitoring using a wearable device for clinical research, providing data on heart rate, ECG, and movement. In contrast, iPredict Eye Screening is an AI-powered tool for early detection of retinal diseases and risk prediction for systemic conditions like stroke and heart attack, utilizing retinal image analysis. While both leverage AI for health insights and touch upon cardiovascular and neurological health, their methodologies and primary applications are distinct, making them adjacent rather than direct competitors.
Choose Study Watch if…
Choose the Verily Study Watch if your clinical research requires continuous, multi-parameter physiological data collection over extended periods. This prescription-only wearable is ideal for studies focusing on detailed ECG, heart rate, movement, and electrodermal activity analysis, leveraging its long battery life and cloud-based machine learning for in-depth insights.
View Study Watch →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if you need a rapid, AI-powered solution for routine screening of retinal diseases like AMD, DR, and Glaucoma in a primary care or telemedicine setting. This tool is particularly well-suited for high-volume environments where quick, accurate results are crucial for early detection and systemic disease risk prediction.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Study Watch | iPredict Eye Screening |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Study Watch | iPredict Eye Screening |
|---|---|---|
| Name | Study Watch | iPredict Eye Screening |
| Company | Verily Life Sciences | iHealthScreen |
| Description | Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. | FDA-cleared AI-powered screening tool for age-related macular degeneration (AMD) in patients aged 50 years and older, alongside screening for Diabetic Retinopathy (DR) and Glaucoma. The platform also provides risk prediction for systemic diseases like stroke and heart attack, integrating with EHR and telemedicine services. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Neurology AI, Ophthalmology AI |
| Specialties | Cardiology, Neurology, Sleep Medicine | Family Medicine, Internal Medicine, Ophthalmology |
| Key Features (Examples) | Continuous physiological monitoring, Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), Long battery life (up to one week) | AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma, Electronic Health Record (EHR) Solutions, AI-Based Telemedicine Service |
Videos
Demos, reviews, and walkthroughs featuring Study Watch and iPredict Eye Screening.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
The Verily Study Watch is a prescription-only wearable device designed for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement. It is intended for use by healthcare professionals and adult patients (22 years or older) with known or suspected heart conditions, and health-conscious individuals. iPredict Eye Screening is an AI-powered screening tool for age-related macular degeneration (AMD) in patients aged 50 years and older, diabetic retinopathy (DR), and glaucoma, also providing risk prediction for systemic diseases like stroke and heart attack.
The Verily Study Watch collects continuous physiological data via multiple sensors, including ECG, heart rate, electrodermal activity, and inertial movements, for analysis in Verily's cloud platform. iPredict Eye Screening utilizes AI to analyze high-resolution retinal images captured by a color fundus camera to screen for eye diseases and predict risks for systemic conditions.
The Verily Study Watch is primarily suited for specialties such as Cardiology, Neurology, and Sleep Medicine, given its focus on continuous physiological monitoring. iPredict Eye Screening is best suited for Family Medicine, Internal Medicine, and Ophthalmology, as it provides AI-based screening for retinal diseases and systemic risk prediction.